StonvexLoading…
StonvexCore line items from AUR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.00M | $0.00 | $0.00 | $150.00M |
Operating Income | $-901.00M | $-786.00M | $-835.00M | $-1.85B |
Net Income | $-816.00M | $-748.00M | $-796.00M | $-1.72B |
EPS (Diluted) | $-0.44 | $-0.46 | $-0.60 | $-1.51 |
Total Assets | $2.34B | $2.14B | $2.23B | $2.00B |
Total Liabilities | $203.00M | $263.00M | $250.00M | $217.00M |
Cash & Equivalents | $221.00M | $211.00M | $501.00M | $262.00M |
Free Cash Flow OCF − CapEx | $-612.00M | $-645.00M | $-613.00M | $-523.00M |
Shares Outstanding | 1.94B | 1.73B | 1.53B | 1.17B |